Abbott India Ltd.
- ECONOMY
Abbott India Q1 Review – Margins Contract; Stock Fairly Priced: ICICI Securities
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
India Pharma – Yet Another Quarter Of Double-Digit Growth For The IPM: Anand Rathi
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Pharma, Healthcare Q1 Preview – Expect Tepid Performance With High Base, Elevated Costs: ICICI Securities
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Pharma Q1 Earnings Preview – Recovery In U.S. But High Domestic Base To Weigh: ICICI Direct
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Q1 FY23 Earnings Preview – Management Commentaries On Demand Critical: Axis Securities
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Pharma Q1 Earnings Preview – Cost Pressure Remains: Centrum Broking
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More »
